Costs of adjuvant breast cancer treatments.

摘要: Breast cancer is the leading incident and second highest cause of mortality in U.S. In 2004, breast treatment expenditures were $8.1 billion [1], may account for as much 1% healthcare [2]. Increased early detection has led to a shift towards diagnosis stage with array adjuvant therapies available, average survival improved over time [3]. Primary therapy commonly surgery. Following surgery, chemotherapy endocrine are used alone or combination kill cells that have spread throughout body, because high percentage patients localized disease undetectable metastases [4].